NIDDK offers a grant for Clinical Centers to study and understand the glycemic changes throughout pregnancy, focusing on dysglycemia evolution. Centers will recruit and observe pregnant women from first trimester to delivery aiming to improve screening for GDM and inform future clinical trials. A cooperative research consortium will be formed with NIDDK to implement a standardized protocol. Applications must detail study design and recruitment capacity. Separate applications for a Biostatistics Research Center are required (RFA-DK-18-019). This grant aims to reduce adverse perinatal outcomes and long-term effects of dysglycemia in pregnant women and their offspring.
Opportunity ID: 309500
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | RFA-DK-18-018 |
Funding Opportunity Title: | Understanding the Glycemic Profile of Pregnancy – Clinical Centers (U01 Clinical Trial Not Allowed) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement |
Category of Funding Activity: | Food and Nutrition Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Oct 11, 2018 |
Last Updated Date: | – |
Original Closing Date for Applications: | Mar 26, 2019 |
Current Closing Date for Applications: | Mar 26, 2019 |
Archive Date: | May 01, 2019 |
Estimated Total Program Funding: | – |
Award Ceiling: | $500,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education For profit organizations other than small businesses Special district governments Independent school districts County governments Public and State controlled institutions of higher education Small businesses Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal governments (Federally recognized) Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | This FOA invites applications for Clinical Centers to carefully characterize the normal course of glycemia over the entire duration of pregnancy and understand the evolution of dysglycemia when it occurs. Clinical Centers will recruit and study pregnant women starting in the first trimester and continuing at least through delivery. A separate FOA (RFA-DK-18-019) will solicit a Biostatistics Research Center. Each Clinical Center applicant will propose a study design and provide detailed information about recruitment capacity. All awardees will form a cooperative research consortium in conjunction with NIDDK to design and implement a uniform protocol. Information obtained from this study is expected to lead to improved approaches for screening for GDM, and inform the timing and approach for future clinical trials to decrease adverse perinatal outcomes and long-term sequelae of dysglycemia during pregnancy in both the mother and offspring. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-018.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-E | FORMS-E | PKG00245538 | Feb 26, 2019 | Mar 26, 2019 | View |
Package 1
Mandatory forms
309500 RR_SF424_2_0-2.0.pdf
309500 PHS398_CoverPageSupplement_4_0-4.0.pdf
309500 RR_OtherProjectInfo_1_4-1.4.pdf
309500 PerformanceSite_2_0-2.0.pdf
309500 RR_KeyPersonExpanded_2_0-2.0.pdf
309500 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
309500 RR_Budget_1_4-1.4.pdf
309500 RR_SubawardBudget30_1_4-1.4.pdf
309500 PHS398_ModularBudget_1_2-1.2.pdf
309500 PHS_AssignmentRequestForm_2_0-2.0.pdf